Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements

靶向二代测序揭示了伴有MYC和BCL2和/或BCL6重排的高级别B细胞淋巴瘤中CREBBP、BCL2和KMT2D的高突变频率。